销售-话题@MedSci

#销售#

155篇内容 | 3147人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687255, encodeId=c2df168e2558e, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=盘点2014年全球销售理想的25个药物, objectType=article, longId=47526, objectId=bd474e526af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd474e526af, replyNumber=0, likeNumber=73, createdTime=2015-10-23, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd474e526af, moduleTitle=盘点2014年全球销售理想的25个药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd474e526af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687259, encodeId=9cad168e25945, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=FDA批准重度抑郁症和精神分裂症重磅新药Rexulti，销售峰值13亿美元, objectType=article, longId=53304, objectId=ce505330419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce505330419, replyNumber=0, likeNumber=71, createdTime=2016-01-31, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce505330419, moduleTitle=FDA批准重度抑郁症和精神分裂症重磅新药Rexulti，销售峰值13亿美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce505330419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687254, encodeId=8ce2168e25458, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=全球销售增长快速的50个药品（2013Q4-2014Q3）, objectType=article, longId=42827, objectId=8afa4282e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8afa4282e25, replyNumber=0, likeNumber=133, createdTime=2015-05-19, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8afa4282e25, moduleTitle=全球销售增长快速的50个药品（2013Q4-2014Q3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8afa4282e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687253, encodeId=a269168e25309, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=恒瑞医药耗巨资获欧美认证海外销售难推广, objectType=article, longId=37084, objectId=c0423e08460, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0423e08460, replyNumber=0, likeNumber=97, createdTime=2014-08-08, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0423e08460, moduleTitle=恒瑞医药耗巨资获欧美认证海外销售难推广, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0423e08460)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687257, encodeId=bf8b168e25780, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=2014 跨国药企在华销售额孰胜孰败？, objectType=article, longId=48092, objectId=a1b74809207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1b74809207, replyNumber=0, likeNumber=64, createdTime=2015-12-31, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1b74809207, moduleTitle=2014 跨国药企在华销售额孰胜孰败？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1b74809207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687248, encodeId=597c168e248f1, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=FDA暂停阿瑞雅德旗下白血病药物Iclusig的销售, objectType=article, longId=26205, objectId=fd9b262058c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd9b262058c, replyNumber=0, likeNumber=68, createdTime=2014-09-25, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd9b262058c, moduleTitle=FDA暂停阿瑞雅德旗下白血病药物Iclusig的销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd9b262058c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687252, encodeId=135b168e252b2, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=2013 降糖药物药销售额前十位, objectType=article, longId=36815, objectId=dcf436815b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcf436815b5, replyNumber=0, likeNumber=82, createdTime=2015-02-02, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcf436815b5, moduleTitle=2013 降糖药物药销售额前十位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcf436815b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687250, encodeId=2a03168e250e1, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=葛兰素史克取消医药代表销售目标, objectType=article, longId=28237, objectId=edb12823e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb12823e1c, replyNumber=0, likeNumber=66, createdTime=2014-07-30, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb12823e1c, moduleTitle=葛兰素史克取消医药代表销售目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edb12823e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687251, encodeId=c8f8168e2518d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=2013年全球大药企重磅药物销售额一览, objectType=article, longId=30401, objectId=8ae43040103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae43040103, replyNumber=0, likeNumber=68, createdTime=2014-02-17, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae43040103, moduleTitle=2013年全球大药企重磅药物销售额一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae43040103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687249, encodeId=b2c5168e24973, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=FDA宣布暂停销售白血病治疗药物ponatinib, objectType=article, longId=26439, objectId=8eba26439a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eba26439a5, replyNumber=0, likeNumber=74, createdTime=2014-08-12, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eba26439a5, moduleTitle=FDA宣布暂停销售白血病治疗药物ponatinib, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eba26439a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687246, encodeId=e731168e246e4, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=FDA咨询委员会建议终止鲑降钙素销售, objectType=article, longId=17076, objectId=b3e81e0760f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3e81e0760f, replyNumber=0, likeNumber=58, createdTime=2013-11-17, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3e81e0760f, moduleTitle=FDA咨询委员会建议终止鲑降钙素销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3e81e0760f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687247, encodeId=3755168e2476f, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=国家食药监总局：自7月起停止生产销售使用甲丙氨酯制剂, objectType=article, longId=19338, objectId=d096193382b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d096193382b, replyNumber=0, likeNumber=67, createdTime=2014-05-06, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d096193382b, moduleTitle=国家食药监总局：自7月起停止生产销售使用甲丙氨酯制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d096193382b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687245, encodeId=3cd0168e24595, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=FDA咨询委员会建议终止鲑降钙素销售, objectType=article, longId=15968, objectId=8575159688b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8575159688b, replyNumber=0, likeNumber=75, createdTime=2013-09-23, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8575159688b, moduleTitle=FDA咨询委员会建议终止鲑降钙素销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8575159688b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687244, encodeId=1f3f168e2440d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=辽宁药监局暂停销售4种严重违规广告药品, objectType=article, longId=11303, objectId=b6ed1130326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6ed1130326, replyNumber=0, likeNumber=80, createdTime=2013-07-16, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6ed1130326, moduleTitle=辽宁药监局暂停销售4种严重违规广告药品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6ed1130326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687243, encodeId=1e05168e2430b, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=SFDA停止生产销售和使用盐酸克仑特罗片剂, objectType=article, longId=3142, objectId=880e314271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=880e314271, replyNumber=0, likeNumber=77, createdTime=2012-04-17, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=880e314271, moduleTitle=SFDA停止生产销售和使用盐酸克仑特罗片剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=880e314271)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

销售

2020-05-29

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

盘点2014年全球销售理想的25个药物

2015-10-23

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

FDA批准重度抑郁症和精神分裂症重磅新药Rexulti，销售峰值13亿美元

2016-01-31

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

全球销售增长快速的50个药品（2013Q4-2014Q3）

2015-05-19

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

恒瑞医药耗巨资获欧美认证海外销售难推广

2014-08-08

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

2014 跨国药企在华销售额孰胜孰败？

2015-12-31

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

FDA暂停阿瑞雅德旗下白血病药物Iclusig的销售

2014-09-25

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

2013 降糖药物药销售额前十位

2015-02-02

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

葛兰素史克取消医药代表销售目标

2014-07-30

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

2013年全球大药企重磅药物销售额一览

2014-02-17

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

FDA宣布暂停销售白血病治疗药物ponatinib

2014-08-12

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

FDA咨询委员会建议终止鲑降钙素销售

2013-11-17

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

国家食药监总局：自7月起停止生产销售使用甲丙氨酯制剂

2014-05-06

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

FDA咨询委员会建议终止鲑降钙素销售

2013-09-23

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

辽宁药监局暂停销售4种严重违规广告药品

2013-07-16

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

SFDA停止生产销售和使用盐酸克仑特罗片剂

2012-04-17

科室
- - 订阅+
  - 更多科室
工具
服务